410 related articles for article (PubMed ID: 35856226)
1. [Sacubitril/valsartan attenuates left ventricular remodeling and improve cardiac function by upregulating apelin/APJ pathway in rats with heart failure].
Liu HZ; Gao CY; Yuan F; Xu Y; Tian H; Wang SQ; Zhang PF; Shi YN; Wei JJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Jul; 50(7):690-697. PubMed ID: 35856226
[No Abstract] [Full Text] [Related]
2. The effect of Sacubitril/Valsartan on cardiac function and cardiac remodeling in patients with heart failure with reduced ejection fraction.
Chen F; Tian G; Bai X; Li J; Yuan Z
Ann Palliat Med; 2021 Aug; 10(8):8684-8691. PubMed ID: 34488357
[TBL] [Abstract][Full Text] [Related]
3. [Effect of sacubitril/valsartan on cardiac function in heart failure rabbits with preserved ejection fraction].
Gao SY; Yao DH; Li JF; Xie QM; Jiang SC
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):887-893. PubMed ID: 31744278
[No Abstract] [Full Text] [Related]
4. Effect of sacubitril valsartan on cardiac function and endothelial function in patients with chronic heart failure with reduced ejection fraction.
Li BH; Fang KF; Lin PH; Zhang YH; Huang YX; Jie H
Clin Hemorheol Microcirc; 2021; 77(4):425-433. PubMed ID: 33386797
[TBL] [Abstract][Full Text] [Related]
5. [Protective effects of berberine against exhaustion exercise induced myocardial injury in rats].
Wang YW; Li XD; Sun MJ; Liu ZP; Liu SW
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Aug; 47(8):647-652. PubMed ID: 31434437
[No Abstract] [Full Text] [Related]
6. Study on the application effect of bisoprolol combined with sacubitril valsartan sodium tablets in the cardiac rehabilitation of patients with acute myocardial infarction combined with left heart failure after percutaneous coronary intervention (PCI).
Chen C; Wu X; Li Y; Peng Y
Ann Palliat Med; 2021 May; 10(5):5455-5461. PubMed ID: 34044572
[TBL] [Abstract][Full Text] [Related]
7. The reverse remodeling response to sacubitril/valsartan therapy in heart failure with reduced ejection fraction.
Martens P; Beliën H; Dupont M; Vandervoort P; Mullens W
Cardiovasc Ther; 2018 Aug; 36(4):e12435. PubMed ID: 29771478
[TBL] [Abstract][Full Text] [Related]
8. Improved heart function and cardiac remodelling following sacubitril/valsartan in acute coronary syndrome with HF.
Liu H; Su Y; Shen J; Jiao Y; Li Y; Liu B; Hou X; Jin Q; Chen Y; Sun Z; Xi Q; Feng B; Fu Z
ESC Heart Fail; 2024 Apr; 11(2):937-949. PubMed ID: 38224955
[TBL] [Abstract][Full Text] [Related]
9. Left ventricular reverse remodeling following initiation of sacubitril/valsartan for heart failure with reduced ejection fraction and low blood pressure.
Nishihara Y; Nishimori M; Sawa T; Uemura K; Nagai S; Todo S; Oota E; Odajima S; Takeuchi K; Ichikawa Y; Kintsu M; Yamauchi Y; Shiraki H; Yamashita K; Fukuda T; Hisamatsu E; Shimizu M; Hirata KI; Tanaka H
Heart Vessels; 2024 Feb; 39(2):95-104. PubMed ID: 37733071
[TBL] [Abstract][Full Text] [Related]
10. Effects of sacubitril-valsartan on remodelling, fibrosis and mitochondria in a murine model of isoproterenol-induced left ventricular dysfunction.
Vergaro G; Del Franco A; Carecci A; Ferrari Chen YF; Aimo A; Forini F; Nicolini G; Kusmic C; Faita F; Castiglione V; De Tata V; Pucci A; Musetti V; Burchielli S; Passino C; Emdin M
Int J Cardiol; 2024 Aug; 409():132203. PubMed ID: 38795973
[TBL] [Abstract][Full Text] [Related]
11. Comparative and Combinatorial Effects of Resveratrol and Sacubitril/Valsartan alongside Valsartan on Cardiac Remodeling and Dysfunction in MI-Induced Rats.
Raj P; Sayfee K; Parikh M; Yu L; Wigle J; Netticadan T; Zieroth S
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443591
[TBL] [Abstract][Full Text] [Related]
12. [Beneficial effects and related mechanism of hawthorn leaves flavonoids on cardiac function in rats with acute myocardial infarction].
Zhang XH; Liu JD; Yu FW; Wang DW
Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Jul; 49(7):701-707. PubMed ID: 34256438
[No Abstract] [Full Text] [Related]
13. Sacubitril/valsartan ameliorates cardiac function and ventricular remodeling in CHF rats via the inhibition of the tryptophan/kynurenine metabolism and inflammation.
Gan J; Wang Y; Deng Y; Zhang J; Wang S; Jiang X; Guo M; Song L
Sci Rep; 2024 May; 14(1):12377. PubMed ID: 38811632
[TBL] [Abstract][Full Text] [Related]
14. Sacubitril/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in heart failure with reduced ejection fraction.
Martens P; Nuyens D; Rivero-Ayerza M; Van Herendael H; Vercammen J; Ceyssens W; Luwel E; Dupont M; Mullens W
Clin Res Cardiol; 2019 Oct; 108(10):1074-1082. PubMed ID: 30788621
[TBL] [Abstract][Full Text] [Related]
15. Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction: The PARALLAX Randomized Clinical Trial.
Pieske B; Wachter R; Shah SJ; Baldridge A; Szeczoedy P; Ibram G; Shi V; Zhao Z; Cowie MR;
JAMA; 2021 Nov; 326(19):1919-1929. PubMed ID: 34783839
[TBL] [Abstract][Full Text] [Related]
16. [Angiotensin(1-7) attenuates left ventricular dysfunction and myocardial apoptosis on rat model of adriamycin-induced dilated cardiomyopathy].
Liu HZ; Gao CY; Wang XQ; Fu HX; Yang HH; Wang XP; Liu YH; Li MW; Niu ZM; Dai GY; Qi DT; Zhang Y
Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Mar; 40(3):219-24. PubMed ID: 22801267
[TBL] [Abstract][Full Text] [Related]
17. The Difference between Sacubitril Valsartan and Valsartan on Vascular Endothelial Function, APN, MMP-9, and BNP Levels in Patients with Hypertension and Chronic Heart Failure.
Du H; Li X; Zhao W; Jiang N
J Healthc Eng; 2022; 2022():9494981. PubMed ID: 35222898
[TBL] [Abstract][Full Text] [Related]
18. Assessment of sacubitril/valsartan effects on left ventricular dynamics using 3D echocardiography and 3D strain in heart failure with reduced ejection fraction patients.
Öz TK; Abdelnabi M; Fiore C; Almaghraby A; Cihan D; Babazade N; Haseeb Raza Naqvi S; Omar B; Dağdeviren B
Minerva Cardiol Angiol; 2022 Aug; 70(4):431-438. PubMed ID: 34713680
[TBL] [Abstract][Full Text] [Related]
19. Canagliflozin Ameliorates Ventricular Remodeling through Apelin/Angiotensin-Converting Enzyme 2 Signaling in Heart Failure with Preserved Ejection Fraction Rats.
Zhang T; Wang X; Wang Z; Zhai J; He L; Wang Y; Zuo Q; Ma S; Zhang G; Guo Y
Pharmacology; 2023; 108(5):478-491. PubMed ID: 37611563
[TBL] [Abstract][Full Text] [Related]
20. Sacubitril/Valsartan Improves Cardiac Function and Decreases Myocardial Fibrosis Via Downregulation of Exosomal miR-181a in a Rodent Chronic Myocardial Infarction Model.
Vaskova E; Ikeda G; Tada Y; Wahlquist C; Mercola M; Yang PC
J Am Heart Assoc; 2020 Jul; 9(13):e015640. PubMed ID: 32538237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
